Ernst & Young (EY) Nigeria has announced the admission of five new partners into the West Africa Partnership, effective July 1, 2024, including Sustainable Development PhD scholar Eunice Sampson.
Get latest articles and stories on India at LatestLY. Jawaharlal Nehru University is mulling abandoning the UGC NET exam for admission to PhD programmes and revert to the in-house entrance, following the cancellation of the NTA-conducted…
Get latest articles and stories on India at LatestLY. The admission into PhD programmes at JNU was supposed to be conducted through the now cancelled UGC NET this academic session.
I'm thrilled to share a story of personal good fortune that supports the promotion of an incredible education-themed film featuring the legendary Malcolm McDowell, which is currently being considered for multiple film festivals.
Zachary Cartwright will host the Scientific and Technical Forum session, "What Technologies are Positively Impacting the Global Water Supply." Each of the esteemed panelists brings extensive experience in applying water technologies,…
Get latest articles and stories on India at LatestLY. A special court in Tamil Nadu's Thanjavur on Tuesday sentenced a PhD scholar to five life imprisonments, to be served concurrently, for sexually assaulting minors and posting videos of…
Dr. Sarma brings exceptional expertise in all facets of the pharmaceutical and biotechnology business, from scaling platforms to developing therapeutics
A young Nigerian, who hails from Osun State, Adedoyin Adeleke, has narrated the reasons why he returned back to Nigeria at a time when other young, able and talented Nigerians were leaving the country in droves. LEADERSHIP reports that in…
"I am confident that Mike is the right person to serve as Lexicon's next chief executive officer at this critical time for the company," said Ray Debbane, chairman of Lexicon's board of directors. "He is an inspiring leader with a…
PALO ALTO, Calif. and RESEARCH TRIANGLE PARK, N.C., July 08, 2024 (GLOBE NEWSWIRE) -- Kriya Therapeutics, Inc. ("Kriya"), a biopharmaceutical company developing gene therapies to address common diseases affecting millions of people around…
"We are excited to welcome Al back to Rhythm as we continue to leverage our understanding of the melanocortin-4 receptor (MC4R) pathway to bring potential therapies to patients and their families," said David Meeker, M.D., Rhythm Chairman,…